Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 151 AL 165

Plasma proteome profiling identified biomarkers for the differential diagnosis and molecular staging of neurodegenerative dementias

Bellomo G, Vermunt L, In 't Veld S, Doecke JD, Hok-A-Hin YS, Veverová K, Houtkamp IM, Alcolea D, Halbgebauer S, Quesada C, Mattsson N, Martinez-Castillo M, López-Martínez MJ, Rábano A, Boonkamp L, Fowler C, Fortea J, Gaetani L, Toja A, Pijnenburg Y, Lemstra A, van der Flier WM, Sánchez-Juan P, Hort J, Otto M, Anderl-Staub S, Sieben A, de Viel B, Engelborghs S, Hansson O, Masters C, Lleó A, Parnetti L, Teunissen CE, Del Campo M.

Nat Aging. 2026 Aug;6(8):1717-1732. doi: 10.1038/s43587-026-01162-7. Epub 2026 Jul 20.

Considerations in Alzheimer's Disease in Women

Just C, Seibert K, Chan C, Maldonado-Correa C, Jones D.

Curr Neurol Neurosci Rep. 2026 Jul 23;26(1):36. doi: 10.1007/s11910-026-01504-3.

Efficacy Measures Used in Alzheimer Disease Clinical Trials Between 2015 and 2025: A Systematic Review

Li C, Fu M, Berg K, Wallach J, Ling K, Wei R, Shi L, Ross J, Guan X.

Neurology. 2026 Aug 25;107(4):e218373. doi: 10.1212/WNL.0000000000218373. Epub 2026 Jul 23.

Role of Exercise in Cardiovascular Disease and Alzheimer's Disease Comorbidity: A Blood Biomarker Perspective

Lu Y, Xu C, Fu P, Gong L.

Cells. 2026 Jul 17;15(14):1284. doi: 10.3390/cells15141284.

Pharmacological and Clinical Heterogeneity of Anti-Amyloid Monoclonal Antibodies in Early Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Trials

Vamanu A, Mastaleru A, Schreiner TG, Popescu G, Roceanu AM, Cucu AI, Patrascu A, Vulpoi GA, Bilcu RV, Cozma RS, Olariu R, Bistriceanu CE, Covali R, Cuciureanu DI, Ciubotaru A.

Med Sci (Basel). 2026 Jun 23;14(3):337. doi: 10.3390/medsci14030337.

Alzheimer's blood-based biomarkers, incident dementia, and interactions with age, APOE status, and hormone therapy

Mielke MM, Gaussoin SA, Casanova R, Latham LA, Manson JE, Mouton CP, Ng TKS, Rapp SR, Resnick SM, Sachs BC, Saquib N, Shadyab AH, McEvoy LK, LaCroix AZ, Wallace RB, Espeland MA, Chen JC, Hayden KM.

Alzheimers Dement. 2026 Jul;22(7):e71704. doi: 10.1002/alz.71704.

Large-Scale Neural Recording Technologies for Investigating Circuit Dysfunction and Functional Biomarker Discovery in Animal Models of Alzheimer's Disease

Sun D, Wang S, Meng Q, Wang X, Amiri M, Unnithan RR, French C.

Int J Mol Sci. 2026 Jul 20;27(14):6444. doi: 10.3390/ijms27146444.

The human retina in Alzheimer's disease: Pathology, mechanisms, and biomarkers

de Sevilla LP, Majumdar S, Recio B.

Ageing Res Rev. 2026 Oct;121:103275. doi: 10.1016/j.arr.2026.103275. Epub 2026 Jul 28.

Motor performance and its association with Alzheimer's-related biomarkers: a systematic review

Serna MF, Mosquera M, García-Perdomo HA.

Neurol Sci. 2026 Jul 31;47(8):672. doi: 10.1007/s10072-026-09253-4.

Biomarker-Based Diagnosis and Care Pathways for Alzheimer's Disease in the Era of Disease-Modifying Treatments: A Consensus Statement by Belgian Experts

Van Langenhove T, Van Mossevelde S, Miatton M, De Lepeleire J, Bruffaerts R, Bier JC, Segers K, Verschraegen J, Petrovic M, Ventura M, Jedidi H, Beyer I, Mormont E, Vandenberghe R, Delva A, Gilles C, Van Weehaeghe D, Picard G, De Deyn P, Strauss M, Thiery E, Salmon E, Cypers G, Vlaemynck J, Gillis K, Versijpt J, Bjerke M, Sieben A, Hanseeuw B, Engelborghs S, Deryck O; BeDeCo members.

Eur J Neurol. 2026 Aug;33(8):e70668. doi: 10.1111/ene.70668.

Adaptive cascading artificial intelligence for Alzheimer's disease assessment: a clinically oriented narrative review and implementation framework

Hooshmandi S, Rahimi Jaberi K, Kamalov F, Nami M.

Neurol Sci. 2026 Aug 3;47(8):678. doi: 10.1007/s10072-026-09282-z.

Plasma p-tau217 detects Alzheimer's disease co-pathology in cerebral amyloid angiopathy: Comparison to CSF biomarkers in the ANGMAR cohort

Fernández-Lebrero A, Jiménez-Balado J, García-Escobar G, Contador J, Estraguès-Gázquez I, Peraferrer-Montesinos L, Manero-Borràs RM, Gramegna LL, Viles M, Campello AR, Ortiz-Romero P, de Diego M, Del Campo M, Torres-Torronteras J, Jiménez-Moyano E, Blasco-Forniés H, Suárez-Calvet M, Ois A, Puig-Pijoan A, Navalpotro-Gómez I.

Alzheimers Dement. 2026 Aug;22(8):e71709. doi: 10.1002/alz.71709.

Lecanemab use in Chinese patients with Alzheimer's disease: a 12-month multicenter real-world study

Wu H, Chen Q, Fang M, Tang H, Liu H, Liu J, Zhang J, Chi L, Liu S, Xin J, Leng L, Wang P, Chi S, Li Y, Chen J, Zhang L, Zhang J, Ma Q, Wang X, Meng X, Nao J, Li X, Lv Y, Jia Y, Zhao Q, Liu C, Gan J, Zhu J, Song Y, Li H, Fei M, Guo X, Liu J, Peng G, Chen X, Ji Y.

Alzheimers Dement. 2026 Aug;22(8):e71702. doi: 10.1002/alz.71702.

Mechanisms, Biomarkers and Therapeutic Implications of Neuroinflammation in Alzheimer's Disease

Papelian S.

Int J Dev Neurosci. 2026 Aug;86(5):e70168. doi: 10.1002/jdn.70168.

A randomized phase 1b/2 trial of ABBV-916 in adults with early Alzheimer's disease

Lynch SY, Wang Y, Wang D, Bachhav SS, Xiong H, Boiser J, Stage E, Bannon AW, Graff O, Florian H.

Alzheimers Dement. 2026 Aug;22(8):e71715. doi: 10.1002/alz.71715.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias